Literature DB >> 18840161

Pregnancy complicated by Caroli's disease with polycystic kidney disease: a case report and following observations.

Mika Tsunoda1, Takashi Ohba, Kikuko Uchino, Hidetaka Katabuchi, Hitoshi Okamura, Shizuo Kaneki.   

Abstract

Caroli's disease and Caroli's syndrome are rare congenital disorders characterized by non-obstructive cystic dilatation of the intrahepatic bile ducts. These disorders are often associated with autosomal recessive polycystic kidney disease. A young woman at 11 weeks of gestation was referred to our hospital for proper management of Caroli's disease during pregnancy. Magnetic resonance imaging and laboratory tests revealed Caroli's disease with chronic renal failure caused by polycystic kidney disease. She received diet control, erythropoietin and prophylactic oral antibiotics. Her pregnancy course was uneventful, and she gave birth at 37 weeks of gestation. Thereafter, her renal function gradually worsened. Hemodialysis was begun 5 years after parturition. Though the courses of pregnancies complicated by Caroli's disease or Caroli's syndrome are variable and can include life-threatening conditions, uneventful outcomes can be expected if careful management prevents biliary and renal infection.

Entities:  

Mesh:

Year:  2008        PMID: 18840161     DOI: 10.1111/j.1447-0756.2008.00891.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Pregnancy in autosomal recessive polycystic kidney disease.

Authors:  Nicole Banks; Joy Bryant; Roxanne Fischer; Marjan Huizing; William A Gahl; Meral Gunay-Aygun
Journal:  Arch Gynecol Obstet       Date:  2014-09-12       Impact factor: 2.344

2.  Imaging manifestations of Caroli disease with autosomal recessive polycystic kidney disease: a case report and literature review.

Authors:  Xiuzhen Yao; Weiqun Ao; Jianhua Fang; Guoqun Mao; Chuanghua Chen; Lifang Yu; Huaijie Cai; Chenke Xu
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-12       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.